Inhibition of the SERPINB5/HSP90AA1 axis restrains the proliferation and invasion of rectal cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.SERPINB5 knockdown inhibits rectal cancer progression by downregulating HSP90AA1. This study reveals SERPINB5 as a potential therapeutic target for rectal cancer treatment.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Serpin family B member 5 (SERPINB5) upregulation is linked to rectal cancer progression.
- The precise roles and mechanisms of SERPINB5 in rectal cancer remain unclear.
Purpose Of The Study
- To elucidate the functional roles and underlying molecular mechanisms of SERPINB5 in rectal cancer.
- To investigate the potential interaction between SERPINB5 and heat shock protein 90 alpha class A member 1 (HSP90AA1).
Main Methods
- Western blot analysis to quantify SERPINB5 levels in rectal cancer tissues and cell lines.
- In vitro assays (transfection, proliferation, invasion, apoptosis) using SW480 cells with manipulated SERPINB5 and HSP90AA1 expression.
- Co-immunoprecipitation to confirm SERPINB5-HSP90AA1 interaction.
- In vivo xenograft mouse model to evaluate the effect of SERPINB5 knockdown on tumor growth.
Main Results
- SERPINB5 was significantly upregulated in rectal cancer tissues and cells.
- SERPINB5 overexpression enhanced cell proliferation and invasion while reducing apoptosis; knockdown yielded opposite effects.
- SERPINB5 interacted with and promoted HSP90AA1 expression, which in turn facilitated cancer progression.
- SERPINB5 knockdown significantly inhibited rectal cancer xenograft tumor growth in vivo.
Conclusions
- SERPINB5 knockdown inhibits rectal cancer cell proliferation and invasion.
- The SERPINB5/HSP90AA1 axis plays a critical role in rectal cancer progression.
- SERPINB5 inhibition of HSP90AA1 expression is a key mechanism underlying its anti-cancer effects, suggesting SERPINB5 as a therapeutic target.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...